Palisade Capital Management LP Invests $12.30 Million in RadNet, Inc. $RDNT

Palisade Capital Management LP acquired a new stake in shares of RadNet, Inc. (NASDAQ:RDNTFree Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 199,431 shares of the medical research company’s stock, valued at approximately $12,299,000. Palisade Capital Management LP owned about 0.25% of RadNet at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Bank of America Corp DE grew its position in RadNet by 15.1% during the first quarter. Bank of America Corp DE now owns 589,610 shares of the medical research company’s stock valued at $32,953,000 after acquiring an additional 77,198 shares during the last quarter. Van Berkom & Associates Inc. lifted its holdings in shares of RadNet by 24.9% in the 1st quarter. Van Berkom & Associates Inc. now owns 1,028,586 shares of the medical research company’s stock worth $57,488,000 after acquiring an additional 204,858 shares during the last quarter. E. Ohman J or Asset Management AB lifted its holdings in shares of RadNet by 1,144.3% in the 2nd quarter. E. Ohman J or Asset Management AB now owns 452,966 shares of the medical research company’s stock worth $27,934,000 after acquiring an additional 416,563 shares during the last quarter. Edmond DE Rothschild Holding S.A. purchased a new stake in shares of RadNet in the 2nd quarter valued at $1,172,000. Finally, Robotti Robert purchased a new stake in shares of RadNet in the 2nd quarter valued at $7,460,000. 77.90% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at RadNet

In other RadNet news, Director David L. Swartz sold 2,699 shares of the stock in a transaction that occurred on Thursday, June 18th. The stock was sold at an average price of $53.89, for a total value of $145,449.11. Following the completion of the sale, the director owned 177,013 shares in the company, valued at approximately $9,539,230.57. This trade represents a 1.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Cornelis Wesdorp sold 4,750 shares of RadNet stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $58.11, for a total value of $276,022.50. Following the completion of the sale, the chief executive officer owned 69,075 shares in the company, valued at approximately $4,013,948.25. This represents a 6.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 5.14% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Truist Financial lifted their target price on shares of RadNet from $90.00 to $94.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Barclays cut their price target on shares of RadNet from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, May 20th. Jefferies Financial Group reaffirmed a “buy” rating on shares of RadNet in a research note on Friday, July 31st. Weiss Ratings reiterated a “sell (d-)” rating on shares of RadNet in a report on Friday, August 7th. Finally, Zacks Research raised RadNet from a “strong sell” rating to a “hold” rating in a research note on Thursday, August 13th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, RadNet has an average rating of “Moderate Buy” and an average target price of $88.00.

View Our Latest Stock Report on RadNet

RadNet Trading Up 2.9%

Shares of RDNT opened at $76.86 on Wednesday. The stock has a market capitalization of $6.05 billion, a P/E ratio of -284.66 and a beta of 1.36. RadNet, Inc. has a twelve month low of $50.82 and a twelve month high of $85.84. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 0.94. The firm has a fifty day simple moving average of $65.99 and a two-hundred day simple moving average of $62.07.

RadNet (NASDAQ:RDNTGet Free Report) last released its quarterly earnings data on Monday, August 10th. The medical research company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.09. The firm had revenue of $622.72 million for the quarter, compared to analysts’ expectations of $610.87 million. RadNet had a negative net margin of 0.93% and a positive return on equity of 2.61%. The company’s revenue for the quarter was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.31 earnings per share. On average, research analysts anticipate that RadNet, Inc. will post 0.49 EPS for the current year.

RadNet Profile

(Free Report)

RadNet, Inc is a leading independent provider of outpatient diagnostic imaging services in the United States. Through a nationwide network of fixed-site imaging centers and affiliated joint-venture locations, the company delivers a comprehensive suite of radiology services including MRI, CT, PET/CT, ultrasound, X-ray, mammography, bone densitometry, nuclear medicine and interventional radiology procedures. RadNet also offers teleradiology and imaging management solutions to physician practices, hospitals and healthcare systems.

Founded in 1981 and headquartered in Los Angeles, RadNet has expanded its footprint organically and through strategic acquisitions.

Recommended Stories

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.